Nearly a year ago, we shared news of FDA approval of tranexamic acid tablets as treatment for heavy menstrual bleeding. Today we learned of successful clinical trials of the drug this purpose: The current issue of Obstetrics & Gynecology includes the results of a double-blind placebo-controlled study of tranexcmic acid tablets, in which the drug “was well tolerated and significantly improved both menstrual blood loss and health-related quality of life in women with heavy menstrual bleeding.”
Clinical Trials for Lysteda
October 11th, 2010 by Elizabeth Kissling
Readers should note that statements published in re: Cycling are those of individual authors and do not necessarily reflect the positions of the Society as a whole.

RSS